Physician profile
Ashok Narayan
NPI 1184626095
$8,808.95
in general payments reported to CMS, 2019-2025
28 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $473 · 2020: $7,412 · 2021: $171 · 2022: $453 · 2023: $125 · 2024: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $7,121.20 | 2019-2022 | |
| Argenx US, INC. | $273.39 | 2022-2024 | Vyvgart, Vyvgart Hytrulo |
| Emd Serono, INC. | $168.55 | 2019-2022 | |
| Sk Life Science, INC. | $159.60 | 2021-2024 | |
| Greenwich Biosciences, INC. | $125.00 | 2020 | |
| Biogen, INC. | $118.12 | 2019-2022 | |
| Avanir Pharmaceuticals, INC. | $117.98 | 2019 | |
| Acadia Pharmaceuticals INC | $89.63 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $80.60 | 2020-2022 | |
| Harmony Biosciences LLC | $74.53 | 2021-2022 | |
| Ucb, INC. | $72.43 | 2019-2022 | |
| Abbvie INC. | $40.23 | 2022-2024 | |
| Alexion Pharmaceuticals, INC. | $37.33 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $35.93 | 2022-2024 | |
| Lilly USA, LLC | $33.42 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $31.83 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $26.79 | 2020-2022 | |
| Ge Healthcare | $25.20 | 2019 | |
| Neurocrine Biosciences, INC. | $24.44 | 2022 | |
| Otto Bock Healthcare Lp | $22.06 | 2022 | |
| Mallinckrodt Hospital Products INC. | $20.66 | 2020 | |
| Neurelis, INC. | $19.53 | 2022 | |
| Upsher-Smith Laboratories LLC | $18.37 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $16.09 | 2021 | |
| Livanova USA, INC. | $15.11 | 2019 | |
| Travere Therapeutics, INC. | $14.94 | 2022 | |
| Aprecia Pharmaceuticals, LLC | $13.39 | 2022 | |
| Supernus Pharmaceuticals, INC. | $12.60 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashok Narayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.